European Healthtech startup funding raised during Q2 2012.
In Q2 2012, 19 European Healthtech companies raised a combined €137M across 19 funding rounds, up 14.5% versus Q2 2011. Netherlands led by capital raised, and 83North was the most active investor. Data as of 7 Aug 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| Agendia | Series D+ | May 2012 | €49M |
| Oxford Nanopore Technologies | Growth/Late | May 2012 | €39M |
| Egalet | Series B | May 2012 | €11M |
| BONESUPPORT | Early VC |
| Jun 2012 |
| €7.8M |
| Gamida Cell | Series D+ | May 2012 | €7.6M |
| Simplee | Series A | May 2012 | €4.5M |
| Spinelab | Series C | May 2012 | €3.7M |
| Alize Pharma | Seed | Jun 2012 | €3.3M |
| Aleva Neurotherapeutics | Series B | Apr 2012 | €3.3M |
| Arctic Diagnostics | Early VC | May 2012 | €2.7M |
| Inbiomotion | Seed | Jun 2012 | €2.1M |
| Sedicidodici | Seed | May 2012 | €900k |
| DrEd Online Doctor | Seed | Jun 2012 | €719k |
| CamStent | Early VC | May 2012 | €615k |
| Alchemy Pharmatech | Early VC | Jun 2012 | €500k |
